Ethical Challenges to Cell-Based Interventions for the Central Nervous System: Some Recommendations for Clinical Trials and Practice

&
American Journal of Bioethics 9 (5):41-43 (2009)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1080/15265160902788694

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,322

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Allowing Innovative Stem Cell-Based Therapies Outside of Clinical Trials: Ethical and Policy Challenges.Insoo Hyun - 2010 - Journal of Law, Medicine and Ethics 38 (2):277-285.
Ethical Challenges in Cell-Based Interventions for Neurological Conditions: Some Lessons To Be Learnt from Clinical Transplantation Trials in Patients with Parkinson's Disease.Elisabeth Hildt - 2009 - American Journal of Bioethics 9 (5):37-38.
Efficacy Testing as a Primary Purpose of Phase 1 Clinical Trials: Is it Applicable to First-in-Human Bionics and Optogenetics Trials?Frederic Gilbert, Alexander R. Harris & Robert M. I. Kapsa - 2012 - American Journal of Bioethics Neuroscience 3 (2):20-22.
Resolving Ethical Issues in Stem Cell Clinical Trials: The Example of Parkinson Disease.Bernard Lo & Lindsay Parham - 2010 - Journal of Law, Medicine and Ethics 38 (2):257-266.
Early Stopping of Clinical Trials: Charting the Ethical Terrain.Erik Malmqvist, Niklas Juth, Niels Lynöe & Gert Helgesson - 2011 - Kennedy Institute of Ethics Journal 21 (1):51-78.
Evaluating the First-in-Human Clinical Trial of a Human Embryonic Stem Cell-Based Therapy.Audrey R. Chapman & Courtney C. Scala - 2012 - Kennedy Institute of Ethics Journal 22 (3):243-261.
Safety Issues In Cell-Based Intervention Trials.Liza Dawson, Alison S. Bateman-House, Dawn Mueller Agnew, Hilary Bok, Dan W. Brock, Aravinda Chakravarti, Mark Greene, Patricia King, Stephen J. O'Brien, David H. Sachs, Kathryn E. Schill, Andrew Siegel & Davor Solter - 2003 - Fertility and Sterility 80 (5):1077-1085.
Uncertain translation, uncertain benefit and uncertain risk: Ethical challenges facing first-in-human trials of induced pluripotent stem (ips) cells.Ronald K. F. Fung & Ian H. Kerridge - 2011 - Bioethics 27 (2):89-96.
Neuro-technical interfaces to the central nervous system.Thomas Stieglitz - 2006 - Poiesis and Praxis 4 (2):95-109.
Unique ethical concerns in clinical trials comparing psychosocial and psychopharmalogical interventions.Lisa R. Stines & Norah C. Feeny - 2008 - Ethics and Behavior 18 (2-3):234 – 246.
Questions Concerning the Clinical Translation of Cell-Based Interventions under an Innovation Pathway.Jeremy Sugarman - 2012 - Journal of Law, Medicine and Ethics 40 (4):945-950.
The science and ethics of placebo in pediatric psychopharmacology.Lawrence Scahill, Mary Solanto & Joseph McGuire - 2008 - Ethics and Behavior 18 (2-3):266 – 285.
Ethicovigilance in clinical trials.David Shaw & Alex Mcmahon - 2012 - Bioethics 27 (9):508-513.

Analytics

Added to PP
2010-09-14

Downloads
14 (#956,614)

6 months
6 (#506,019)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Add more citations

References found in this work

Add more references